It wouldnt surprise me that improving peoples health this way actually slows down the ageing process. The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes
Semaglutide GLP-1 also decreases the release of glucose from liver stores into the circulation, contributing to overall better blood sugar management
Semaglutide has emerged as a treatment option for type 2 diabetes, offering substantial improvements in health outcomes
The strongest modifiable determinants of effect duration are: Accurate placement, at or near the motor end-plate - solid anatomical knowledge is paramount Appropriate dosage Correct patient selection
seek urgent attention for severe vomiting, abdominal pain, or signs of allergic reaction